Literature DB >> 3724661

Clinical, epidemiologic, and therapeutic aspects of Lassa fever.

J B McCormick.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3724661     DOI： 10.1007/bf02122438

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN： 0300-8584            Impact factor:   3.402


× No keyword cloud information.
  31 in total

Review 1.  Coverage of related pathogenic species by multivalent and cross-protective vaccine design: arenaviruses as a model system.

Authors:  Jason Botten; John Sidney; Bianca R Mothé; Bjoern Peters; Alessandro Sette; Maya F Kotturi
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

2.  Development of peptide-conjugated morpholino oligomers as pan-arenavirus inhibitors.

Authors:  Benjamin W Neuman; Lydia H Bederka; David A Stein; Joey P C Ting; Hong M Moulton; Michael J Buchmeier
Journal:  Antimicrob Agents Chemother       Date:  2011-08-08       Impact factor: 5.191

3.  Identification of protective Lassa virus epitopes that are restricted by HLA-A2.

Authors:  Jason Botten; Jeff Alexander; Valerie Pasquetto; John Sidney; Polly Barrowman; Joey Ting; Bjoern Peters; Scott Southwood; Barbara Stewart; Maria P Rodriguez-Carreno; Bianca Mothe; J Lindsay Whitton; Alessandro Sette; Michael J Buchmeier
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  A Case of Human Lassa Virus Infection With Robust Acute T-Cell Activation and Long-Term Virus-Specific T-Cell Responses.

Authors:  Anita K McElroy; Rama S Akondy; Jessica R Harmon; Ali H Ellebedy; Deborah Cannon; John D Klena; John Sidney; Alessandro Sette; Aneesh K Mehta; Colleen S Kraft; Marshall G Lyon; Jay B Varkey; Bruce S Ribner; Stuart T Nichol; Christina F Spiropoulou
Journal:  J Infect Dis       Date:  2017-06-15       Impact factor: 5.226

Review 5.  Epidemiology and Management of the 2013-16 West African Ebola Outbreak.

Authors:  M L Boisen; J N Hartnett; A Goba; M A Vandi; D S Grant; J S Schieffelin; R F Garry; L M Branco
Journal:  Annu Rev Virol       Date:  2016-08-15       Impact factor: 10.431

6.  Polyfunctional CD4+ T cell responses to a set of pathogenic arenaviruses provide broad population coverage.

Authors:  Maya F Kotturi; Jason Botten; Matt Maybeno; John Sidney; Jean Glenn; Huynh-Hoa Bui; Carla Oseroff; Shane Crotty; Bjoern Peters; Howard Grey; Daniel M Altmann; Michael J Buchmeier; Alessandro Sette
Journal:  Immunome Res       Date:  2010-05-17

7.  Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects.

Authors:  Luis M Branco; Jessica N Grove; Lina M Moses; Augustine Goba; Mohammed Fullah; Mambu Momoh; Randal J Schoepp; Daniel G Bausch; Robert F Garry
Journal:  Virol J       Date:  2010-11-09       Impact factor: 4.099

8.  Development of infectious clones for virulent and avirulent pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers.

Authors:  Shuiyun Lan; Lisa McLay Schelde; Jialong Wang; Naveen Kumar; Hinh Ly; Yuying Liang
Journal:  J Virol       Date:  2009-04-22       Impact factor: 5.103

9.  Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding.

Authors:  Megan M Illick; Luis M Branco; Joseph N Fair; Kerry A Illick; Alex Matschiner; Randal Schoepp; Robert F Garry; Mary C Guttieri
Journal:  Virol J       Date:  2008-12-23       Impact factor: 4.099

10.  Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms.

Authors:  Luis M Branco; Robert F Garry
Journal:  Virol J       Date:  2009-09-24       Impact factor: 4.099
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.